Aller au contenu
Sommeil et rythmesEssai randomisé4 min read

Pre-sleep casein, α-lactalbumin or carbs did not worsen sleep in elite female athletes

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Pre-sleep milk-derived proteins do not impair sleep or recovery in elite female athletes. · Journal of the International Society of Sports Nutrition · 2026 · Article original ↗

À retenir

In 21 NCAA Division I female athletes, three nights of a 40 g pre-sleep casein, α-lactalbumin or carbohydrate drink did not change WHOOP-measured sleep, resting heart rate or HRV compared with placebo (all p > 0.05). The trial tested whether these drinks do harm, over only three nights per condition, so it does not show any benefit.

Study design

Essai randomisé

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Athletes often sleep poorly or too little, and eating before bed is used to aid recovery, but few controlled trials have compared different pre-sleep macronutrients on objective and subjective sleep in elite female athletes. The authors tested whether casein, α-lactalbumin or carbohydrate before bed would impair sleep or recovery compared with a placebo.

Population et méthode

Randomized, double-blinded, placebo-controlled crossover trial over 4-8 weeks in 25 NCAA Division I female athletes aged 18-25 years, of whom 21 completed it. Each athlete took four treatments for three consecutive nights each, with at least a three-day washout: 40 g casein (CAS; 160 kcal), 40 g α-lactalbumin (ALA; 160 kcal), 40 g carbohydrate (CHO; 160 kcal) and 40 g placebo (PLA; 5 kcal), about 2 h after the last meal and about 30 min before bed. A WHOOP 4.0 device recorded total sleep time, sleep onset latency, sleep efficiency, resting heart rate and HRV. Morning questionnaires measured sleep quality, sleep onset latency and recovery. A blinded continuous glucose monitor (CGM) was worn by a subset of 6. Repeated-measures ANOVA and Tukey's post hoc testing were used, with p < 0.05.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    No significant treatment effects were seen for total sleep time, sleep onset latency, sleep efficiency, resting heart rate or HRV (p > 0.05).
  2. 2
    Across conditions, total sleep time ranged from 7.47-7.62 h, sleep efficiency 91.5-92.0%, resting heart rate 53.5-54.1 bpm and HRV 98.2-103.9 ms.
  3. 3
    Subjective sleep quality (69-75%), sleep onset latency (16-20 min) and recovery (61-66%) also showed no significant treatment effects (p > 0.05).
  4. 4
    In the 6-person CGM sub-analysis, nocturnal glucose changed with time (p = 0.008) but did not differ among treatments (p = 0.187) and there was no time × treatment interaction (p = 0.550).

Limites et incertitude

  1. 1
    Only 21 athletes completed it, and the CGM sub-analysis included just 6, so small effects could be missed; the abstract does not report effect sizes or confidence intervals.
  2. 2
    Each treatment lasted only three consecutive nights, so longer-term effects of pre-sleep feeding on sleep or body composition are unknown.
  3. 3
    Sleep staging and timing came from a consumer wearable (WHOOP 4.0) rather than laboratory polysomnography.
  4. 4
    The population was elite collegiate women, so results may not apply to other people. This reading is based on the abstract only.

Mise en perspective

If you are an athlete who wants a pre-bed protein or carbohydrate snack, this suggests a 40 g serving did not noticeably harm sleep or recovery in this group over short periods. It does not show that it helps sleep. Individual tolerance varies, and people with medical or dietary conditions should check with a clinician or dietitian.

Vos données

The trial used WHOOP-style data (sleep duration, efficiency, resting heart rate, HRV), the same metrics many wearables record, and its glucose sub-study used a CGM. To test a late snack yourself, change one thing at a time, keep the device and bedtime the same, and compare averages over several nights rather than single nights, since night-to-night values vary.

Comprendre ce type de preuve

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Sleep is essential for athlete recovery and performance, yet athletes frequently experience restricted or poor-quality sleep. Pre-sleep feeding (PSF) has emerged as a strategy to support recovery, but randomized, double-blinded, crossover trials comparing PSF macronutrient options on objective and subjective sleep outcomes in elite female athletes remain limited.

Methods

Twenty-five National Collegiate Athletic Association (NCAA) Division I female athletes (18-25 years old) were recruited; 21 completed the trial. In a randomized, double-blinded, placebo controlled, crossover design conducted over 4-8 weeks, participants consumed four treatments for three consecutive nights each: 40 g casein protein (CAS; 160 kcal), 40 g α -lactalbumin protein (ALA; 160 kcal), 40 g carbohydrate (CHO; 160 kcal), and 40g of a placebo (PLA; 5 kcal), with a minimum three-day washout between conditions. Supplements were consumed ~2 h after the final meal and ~30 min before bedtime as the last caloric intake of the day. Objective outcomes were obtained from the WHOOP 4.0 device (total sleep time (TST), sleep onset latency (SOL), sleep efficiency (SE), resting heart rate (RHR), and heart rate variability (HRV)). Subjective outcomes were assessed each morning via questionnaires (subjective sleep quality (SSQ), subjective sleep onset latency (SSOL), and subjective recovery (SREC)). Nocturnal interstitial glucose was assessed via blinded continuous glucose monitoring (CGM) in a subset ( n = 6). Sleep and recovery variables were analyzed using one-way repeated-measures analysis of variance (ANOVA) to evaluate treatment effects across the four supplementation conditions. For CGM data, a two-way repeated-measures ANOVA was used to evaluate main effects of treatment and time, as well as the treatment × time interaction. Tukey's post hoc testing was used with significance set at p < 0.05.

Results

No significant treatment effects were observed for TST, SOL, SE, RHR, or HRV ( p > 0.05). TST ranged from 7.47-7.62 h, SE from 91.5-92.0%, RHR from 53.5-54.1 bpm, and HRV from 98.2-103.9 ms across conditions. No significant treatment effects were detected for SSQ, SSOL, or SREC ( p > 0.05); SSQ ranged from 69-75%, SSOL from 16-20 min, and SREC from 61-66%. In the CGM sub-analysis, a main effect of time was observed for nocturnal glucose ( p = 0.008), but no differences among treatments ( p = 0.187) or a time × treatment interaction ( p = 0.550) were detected.

Conclusions

In NCAA Division I female athletes, three consecutive nights of pre-sleep ingestion of CAS, ALA, or CHO did not impair objective or subjective measures of sleep or recovery compared with PLA. These findings demonstrate that pre-sleep feeding, regardless of macronutrient type, can be incorporated without negatively affecting sleep quality or recovery metrics.

Trial registration

ClinicalTrials.gov (Identifier: STUDY00004409).

Sources et attribution

Pre-sleep milk-derived proteins do not impair sleep or recovery in elite female athletes.

Paterson KGP, Griest TD, Angeles E, Fenner SP, Eberhardt HK, McKay CR, Helms KLW, Calderon A, Vukovich MD, Ormsbee MJ.

Journal of the International Society of Sports Nutrition · 2026-10-20

DOI: 10.1080/15502783.2026.2746899 ↗PubMed · 42897977 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Méta-analyse d’essais

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

Explications approfondiesLire l’étude →
·Étude de cohorte

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

Explications approfondiesLire l’étude →
·Essai randomisé

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

Explications approfondiesLire l’étude →
·Étude de cohorte

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

Explications approfondiesLire l’étude →
Sommeil et rythmes →